Literature DB >> 25413619

Stroke unit management and revascularisation in acute ischemic stroke.

Simon Jung1, Christian Stapf, Marcel Arnold.   

Abstract

BACKGROUND: Stroke affects one in six people throughout their lifetimes and is the most frequent cause of disability in adults. Several recanalization therapies have emerged and the management of patients in stroke units has improved over the last decades.
SUMMARY: This article examines the current treatment options for stroke patients, summarizing the key clinical evidence, as well as listing the complications and practical issues related to each of these main treatment options. KEY MESSAGES: Recent advances in the treatment of acute stroke include developments in intravenous thrombolysis (IVT), intra-arterial treatment and bridging therapies. CLINICAL IMPLICATIONS: Treatment within a stroke unit reduces mortality and disability regardless of age, sex and stroke severity. IVT is widely available and reduces disability when initiated within 4.5 h after the onset of symptoms. The major limitations of IVT are the low recanalization rates and the narrow time frame. Intra-arterial treatment, especially when using newly developed stent-retrievers, achieves very high recanalization rates. It is restricted by its limited availability and by the longer time span required to initiate therapy. Bridging both therapies is a promising approach that combines the advantages of both therapies, but the superiority of this approach remains to be proven. Future strategies to reduce the burden of acute stroke in Europe should focus on immediate access to acute stroke care and dedicated stroke units for all patients.

Entities:  

Mesh:

Year:  2014        PMID: 25413619     DOI: 10.1159/000365210

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

Review 1.  [Appropriate treatment of acute stroke at all times and in all places : Organizational concepts and new approaches].

Authors:  J E Weber; H J Audebert
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

2.  Salivary Xanthine Oxidase as a Potential Biomarker in Stroke Diagnostics.

Authors:  Mateusz Maciejczyk; Miłosz Nesterowicz; Anna Zalewska; Grzegorz Biedrzycki; Piotr Gerreth; Katarzyna Hojan; Karolina Gerreth
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 3.  Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives.

Authors:  Diji Kuriakose; Zhicheng Xiao
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.